Represented Oklahoma Medical Research Foundation (OMRF) in a suit against Eli Lilly in the Western District of Oklahoma. OMRF alleged patent infringement and breach of a license agreement in connection with Eli Lilly's sales of Xigris, the first FDA-approved drug to treat severe sepsis. The suit settled on the eve of trial after more than 60 depositions, production of more than one million pages of documents by Eli Lilly, and a Markman hearing resulting in a claim construction favorable to our client.

Oklahoma Med. Research Found. v. Eli Lilly & Co., No. 01-0456 (W.D. Okla. filed Mar. 15, 2001).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Patent procurement and counseling services to YKK Corporation of America
Provide patent procurement and counseling services to YKK Corporation of America, an industry leader in the development of fastening and more
Acquisition by Zodiac Aerospace
Represented Zodiac Aerospace in its acquisition of C&D Aerospace, an aircraft interiors manufacturer with operations in the United States, more
Largest proposed OSHA fine in North Carolina history for HoltraChem Manufacturing Company
Represented the HoltraChem Manufacturing Co. in the largest Occupational Safety and Health Administration (OSHA) fine in North Carolina history. more
Employment litigation for a global snack food manufacturer
Represented a global snack food manufacturer in an appeal from a trial (which we did not handle) of a wrongful discharge more